Homologous recombination repair deficiency (HRD): From biology to clinical exploitation

David Gonzalez , Albrecht Stenzinger

Research output: Contribution to journal › Article › peer-review

21 Citations (Scopus)

371 Downloads (Pure)

Original language	English
Journal	Genes, Chromosomes and Cancer
Early online date	10 Feb 2021
DOIs	https://doi.org/10.1002/gcc.22939
Publication status	Early online date - 10 Feb 2021

Access to Document

Homologous recombination repair deficiency (HRD): From biology to clinical exploitation
Copyright 2021 the authors. This is an open access article published under a Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits distribution and reproduction for non-commercial purposes, provided the author and source are cited.
Final published version, 578 KBLicence: CC BY-NC-ND

@article{932fa1e75284477eab76b06f35a0b291,

title = "Homologous recombination repair deficiency (HRD): From biology to clinical exploitation",

author = "David Gonzalez and Albrecht Stenzinger",

year = "2021",

month = feb,

day = "10",

doi = "10.1002/gcc.22939",

language = "English",

journal = "Genes, Chromosomes and Cancer",

issn = "1045-2257",

publisher = "Wiley-Liss Inc.",

}